alanine has been researched along with ondansetron in 3 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 1 (33.33) | 18.2507 |
2000's | 0 (0.00) | 29.6817 |
2010's | 1 (33.33) | 24.3611 |
2020's | 1 (33.33) | 2.80 |
Authors | Studies |
---|---|
Riekkinen, P; Sirviö, J | 1 |
Damaj, BB; Hu, L; Martin, R; Michniak-Kohn, BB | 1 |
El-Kosasy, AM; Hussein, LA; Mohamed, NM; Salama, NN | 1 |
3 other study(ies) available for alanine and ondansetron
Article | Year |
---|---|
Non-reversal of scopolamine- or age-related EEG changes by ondansetron, methysergide or alaproclate.
Topics: Aging; Alanine; Animals; Antidepressive Agents; Electroencephalography; Electrophysiology; Imidazoles; Male; Methysergide; Ondansetron; Pilocarpine; Rats; Rats, Inbred Strains; Scopolamine; Serotonin Antagonists | 1991 |
Enhanced in vitro transbuccal drug delivery of ondansetron HCl.
Topics: Absorption; Administration, Buccal; Alanine; Animals; Azepines; Chemistry, Pharmaceutical; Drug Compounding; In Vitro Techniques; Iontophoresis; Kinetics; Mouth Mucosa; Ondansetron; Permeability; Sulfur Compounds; Technology, Pharmaceutical | 2011 |
New and validated RP-HPLC Method for Quantification of Safinamide Mesylate in Presence of Its Basic Degradate, Levodopa and Ondansetron: Application to Human Plasma.
Topics: Alanine; Benzylamines; Chromatography, High Pressure Liquid; Chromatography, Reverse-Phase; Humans; Levodopa; Limit of Detection; Linear Models; Ondansetron; Reproducibility of Results; Tablets | 2020 |